Document:

GENERAL RELEASE
AGREEMENT

     

    This
GENERAL RELEASE
AGREEMENT (this “Agreement”), dated as
of October __, 2010, is entered into by and among InVivo Therapeutics Holding
Corp., a Nevada corporation (“Seller”), DSource Split Corp., a Delaware
corporation (“Split-Off Subsidiary”), and Peter Reichard, Peter Coker and
Lawrence Reichard (“Buyers”). In consideration of the mutual benefits to be
derived from this Agreement, the covenants and agreements set forth herein, and
other valuable consideration, the receipt and sufficiency of which are hereby
acknowledged by the execution and delivery hereof, the parties hereto hereby
agree as follows:

     

    1.           Split-Off
Agreement.  This Agreement is
executed and delivered by Split-Off Subsidiary pursuant to the requirements of
Section 8.3 of that certain Split-Off Agreement (the “Split-Off Agreement”) by
and among Seller, Split-Off Subsidiary and Buyers as a condition precedent to
the closing (the “Closing”) of the Split-Off Agreement.

     

    2.           Release
and Waiver by Split-Off Subsidiary.  For and in
consideration of the covenants and promises contained herein and in the
Split-Off Agreement, the receipt and sufficiency of which are hereby
acknowledged, Split-Off Subsidiary, on behalf of itself and its assigns,
representatives and agents, if any, hereby covenants not to sue and fully,
finally and forever completely releases Seller, along with its present, future
and former officers, directors, stockholders, members, employees, agents,
attorneys and representatives (collectively, the “Seller Released Parties”), of
and from any and all claims, actions, obligations, liabilities, demands and/or
causes of action, of whatever kind or character, whether now known or unknown,
which Split-Off Subsidiary has or might claim to have against the Seller
Released Parties for any and all injuries, harm, damages (actual and punitive),
costs, losses, expenses, attorneys’ fees and/or liability or other detriment, if
any, whenever incurred or suffered by Split-Off Subsidiary arising from,
relating to, or in any way connected with, any fact, event, transaction, action
or omission that occurred or failed to occur on or prior to the date of the
Closing.

     

    3.           Release
and Waiver by Buyers.  For and in
consideration of the covenants and promises contained herein and in the
Split-Off Agreement, the receipt and sufficiency of which are hereby
acknowledged, Buyers hereby covenant not to sue and fully, finally and forever
completely release the Seller Released Parties of and from any and all claims,
actions, obligations, liabilities, demands and/or causes of action, of whatever
kind or character, whether now known or unknown which Buyers have or might claim
to have against the Seller Released Parties for any and all injuries, harm,
damages (actual and punitive), costs, losses, expenses, attorneys’ fees and/or
liability or other detriment, if any, whenever incurred or suffered by Buyers
arising from, relating to, or in any way connected with, any fact, event,
transaction, action or omission that occurred or failed to occur on or prior to
the date of the Closing.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    4.           Additional Covenants and
Agreements.

     

    (a)           Each
of Split-Off Subsidiary and Buyers, on the one hand, and Seller, on the other
hand, waives and releases the other from any claims that this Agreement was
procured by fraud or signed under duress or coercion so as to make this
Agreement not binding.

     

    (b)           Each
of the parties hereto acknowledges and agrees that the releases set forth herein
do not include any claims the other party hereto may have against such party for
such party’s failure to comply with or breach of any provision in this Agreement
or the Split-Off Agreement.

     

    (c)           Notwithstanding
anything contained herein to the contrary, this Agreement shall not release or
waive, or in any manner affect or void, any party’s rights and obligations under
the Split-Off Agreement.

     

    5.           Modification.  This Agreement
cannot be modified orally and can only be modified through a written document
signed by both parties.

     

    6.           Severability.  If any provision
contained in this Agreement is determined to be void, illegal or unenforceable,
in whole or in part, then the other provisions contained herein shall remain in
full force and effect as if the provision that was determined to be void,
illegal or unenforceable had not been contained herein.

     

    7.           Expenses.  The parties
hereto agree that each party shall pay its respective costs, including
attorneys’ fees, if any, associated with this Agreement.

     

    8.           Further
Acts and Assurances.  Split-Off Subsidiary and each Buyer
agrees that it will act in a manner supporting compliance, including compliance
by its Affiliates, with all of its obligations under this Agreement and, from
time to time, shall, at the request of Seller, and without further
consideration, cause the execution and delivery of such other instruments of
release or waiver and take such other action or execute such other documents as
such party may reasonably request in order to confirm or effect the releases,
waivers and covenants contained herein, and, in the case of any claims, actions,
obligations, liabilities, demands and/or causes of action that cannot be
effectively released or waived without the consent or approval of other persons
or entities that is unobtainable, to use its best reasonable efforts to ensure
that the Seller Released Parties receive the benefits thereof to the maximum
extent permissible in accordance with applicable law or other applicable
restrictions, and shall perform such other acts which may be reasonably
necessary to effectuate the purposes of this Agreement.  For the
purposes of this Agreement, an “Affiliate” is a person or entity that directly,
or indirectly through one or more intermediaries, controls or is controlled by,
or is under common control with, another specified person or
entity.

     

    9.           Governing
Law.  This Agreement
shall be governed by and construed in accordance with the laws of the State of
New York, without giving effect to principles of conflicts or choice of laws
thereof.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    10.         Entire
Agreement. This
Agreement constitutes the entire understanding and agreement of Seller,
Split-Off Subsidiary and Buyers and supersedes prior understandings and
agreements, if any, among or between Seller, Split-Off Subsidiary and Buyers
with respect to the subject matter of this Agreement, other than as specifically
referenced herein. This Agreement does not, however, operate to supersede or
extinguish any confidentiality, non-solicitation, non-disclosure or
non-competition obligations owed by Split-Off Subsidiary or Buyers to Seller
under any prior agreement.

     

    [Signature
Page Follows]

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    IN WITNESS WHEREOF, the
undersigned have executed this General Release Agreement as of the day and year
first above written.

    

    
      
        
          
            
              
                
                  
                    
                      
                        
                          
                            
                              
                                
                                  
                                    
                                      	 
      	
                                              INVIVO
      THERAPEUTICS HOLDING CORP.

                                            
	 
      	 
      	 
      
	 
      	
                                              By:

                                            	 
      
	 
      	
                                              Name:  Peter
      A. Reichard

                                            
	 
      	
                                              Title:  President

                                            
	 
      	 
      	 
      
	 
      	
                                              DSOURCE
      SPLIT CORP.

                                            
	 
      	 
      	 
      
	 
      	
                                              By:

                                            	 
      
	 
      	
                                              Name:  Peter
      A. Reichard

                                            
	 
      	
                                              Title:  President

                                            
	 
      	 
      	 
      
	 
      	
                                              BUYERS:

                                            
	 
      	 
      	 
      
	 
      	 
      
	 
      	
                                              Peter
      Reichard

                                            
	 
      	 
      	 
      
	 
      	 
      
	 
      	
                                              Peter
      Coker

                                            
	 
      	 
      	 
      
	 
      	 
      
	 
      	
                                              Lawrence
      ReichardInVivo
Therapeutics Corporation

    One
Broadway, 14th
Floor

    Cambridge,
MA 02142

     

    May 31,
2008

     

    Frank
Reynolds

    4116
Barberry Drive

    Lafayette
Hill, PA 19444

     

    Re:        Employment
Agreement

     

    Dear
Frank

     

    This
letter is to confirm our understanding with respect to (i) your future
employment by InVivo
Therapeutics Corporation or any present or future parent, subsidiary or
affiliate thereof (collectively, the “Company”), (ii) your agreement not to
compete with the Company, (iii) your agreement to protect and preserve
information and property which is confidential and proprietary to the Company
and (iv) your agreement with respect to the ownership of inventions, ideas,
copyrights and patents which may be used in the business of the Company (the
terms and conditions agreed to in this letter are hereinafter referred to as the
“Agreement”). In consideration of the mutual promises and covenants contained in
this Agreement, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby mutually acknowledged, we have agreed as
follows:

    

    1.           Employment.

     

    (a)    
     Subject to the terms and conditions of this
Agreement, the Company will employ you, and you will be employed by the Company,
as Chief Executive Officer and President reporting only to the Company’s Board
of Directors (the “Board”).  You will have the responsibilities, duty
and authority commensurate with the position of Chief Executive Officer and
President.  You will also perform such other services of an executive
nature for the Company as may be assigned to you from time to time by the Board
and agreed to by you. The principal location will be the Company’s facility
located at One Broadway, 14th Floor
Cambridge, MA 02142.  During the term of your
employment hereunder, the Company will ensure that you are nominated, and will
use its best efforts to cause you to be elected, to serve as a Director of the
Company and Chairman of the Company’s board of directors and as a member of the
board of directors of any affiliate or subsidiary of the Company and any
committee of the Company or any subsidiary or affiliate of the Company that you
request.

    
      
         

      

      
        
        

        
          

        

      

      
         

      

    

    (b)           Devotion to
Duties.  For so long as you are employed hereunder, you will
devote substantially all of your business time and energies to the business and
affairs of the Company, provided that nothing contained in this Section 1(b)
will be deemed to prevent or limit your right to manage your personal
investments on your own personal time, including, without limitation, the right
to make passive investments in the securities of (i) any entity which you do not
control, directly or indirectly, and which does not compete with the Company, or
(ii) any publicly held entity so long as your aggregate direct and indirect
interest does not exceed five percent of the issued and outstanding securities
of any class of securities of such publicly held entity, and provided, further
that nothing contained in this Agreement will be deemed to prohibit you from any
involvement with any social and/or business organizations, and accepting any
directorships for companies or other organizations.

     

    2.           Term of
Employment.

     

    (a)           Term;
Termination.  Subject to the terms hereof, your employment
hereunder will commence on June 1, 2008 (the “Commencement Date”) and will
continue for indefinitely (the “Term”) unless terminated as specified
herein.

     

    Notwithstanding
the foregoing, your employment hereunder will terminate upon the first to occur
of the following:

     

    (i)           Immediately
upon your death;

     

    (ii)          By
the Company:

     

    (A)          By
written notice to you effective the date of such notice, following your failure,
due to illness, accident or any other physical or mental incapacity, to perform
the essential functions of your position for an aggregate of 90 business days
within any period of 180 consecutive business days during the term hereof as
determined by a physician selected by you (“Disability”), provided that if
applicable law provides any provision regarding disability that is more
favorable to you than that set forth herein, such more favorable provision will
govern; or

     

    (B)           By
written notice to you effective the date of such notice, for Cause (as defined
below).

     

    (iii)         By
you:

     

    (A)          At
any time by written notice to the Company effective 30 days after the date of
such notice; or

     

    (B)           By
written notice to the Company for Good Reason (as defined below) effective the
date of such notice.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    (b)          Definition of
“Cause”.  For purposes of this Agreement, “Cause” means (i)
your conviction of a felony, either in connection with the performance of your
obligations to the Company or which otherwise materially and adversely affects
your ability to perform such obligations, (ii) your willful disloyalty or
deliberate dishonesty, (iii) the commission by you of an act of fraud or
embezzlement against the Company, or (iv) a willful material breach by you of
any material provision of this Agreement which breach is not cured within 60
days after delivery to you by the Company of written notice of such breach,
provided that if such breach is not capable of being cured within such 60 day
period, you will have a reasonable additional period to cure such breach but
only if you promptly commence and continue good faith efforts to cure such
breach.  Any determination under this Section 2(b) will be made by two
thirds of the Board voting on such determination.  With respect to any
such determination, the Board will act fairly and in utmost good faith and will
give you and your counsel an opportunity to appear and be heard at a meeting of
the Board or and present evidence on your behalf.  No act or omission
on your part will be considered “willful” unless done, or admitted to be done,
by you in bad faith or without your reasonable belief that such act or omission
was in the best interest of the Company.

     

    (c)          Definition of “Good
Reason”.  For purposes of this Agreement, a “Good Reason” means
any of the following:

     

    (i)          A
change in the principal location at which you provide services to the Company,
without your prior written consent;

     

    (ii)         Your
failure to be nominated for election to, or to be elected to, the Board, failure
of the Board to appoint you as President of the Company, or removal from the
Board or as
President of the
Company provided that such failure or removal is not in connection with a
termination of your employment hereunder by the Company;

     

    (iii)        A
material adverse change by the Company in your duties, authority or
responsibilities as President and Chief Executive Officer of the Company which
causes your position with the Company to become of less responsibility or
authority than your position as of immediately following the Commencement Date,
provided that such change is not in connection with a termination of your
employment hereunder by the Company;

     

    (iv)        The
assignment to you of duties not commensurate or consistent with your position as
President and Chief Executive Officer of the Company without your prior written
consent;

     

    (v)         A
reduction in your compensation or other benefits except such a reduction in
connection with a general reduction in compensation or other benefits of all
senior executives of the Company;

     

    (vi)        A
material breach of this Agreement by the Company that has not been cured within
30 days after written notice thereof by you to the Company;

     

    (vii)       The
Company ceasing to be engaged in the business of the treatment of Neurological
disease;

     

    (ix)         A
Change of Control (as defined in Section 2(d) below) of the Company; or

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    (x)         Failure
by the Company to obtain the assumption of this Agreement by any successor to
the Company;

     

    (xi)        The
decision by the Company not to renew employment agreement at the end of the term
or any extensions thereof.

     

    (d)       
  Definition
of “Change of Control”  For purposes of this Agreement, a
Change of Control means that any of the following events has
occurred:

     

    (i)       Any
person (as such term is used in Section 13(d) of the Securities Exchange Act of
1934 (the “Exchange Act”)), other than the Company, any employee benefit plan of
the Company or any entity organized, appointed or established by the Company for
or pursuant to the terms of any such plan, together with all “affiliates” and
“associates” (as such terms are defined in Rule 12b-2 under the Exchange Act)
becomes the beneficial owner or owners (as defined in Rule I 3d-3 and 13d-5
promulgated under the Exchange Act), directly or indirectly (the “Control
Group”), of more than 50% of the outstanding equity securities of the Company,
or otherwise becomes entitled, directly or indirectly, to vote more than 50% of
the voting power entitled to be cast at elections for directors (“Voting Power”)
of the Company, provided
that a Change of Control will not have occurred if such Control Group acquired
securities or Voting Power solely by purchasing securities from the Company,
including, without limitation, acquisition of securities by one or more third
party investors such as venture capital investor(s);

     

    (ii)      A
consolidation or merger (in one transaction or a series of related transactions)
of the Company pursuant to which the holders of the Company’s equity securities
immediately prior to such transaction or series of related transactions would
not be the holders, directly or indirectly, immediately after such transaction
or series of related transactions of more than 50% of the Voting Power of the
entity surviving such transaction or series of related
transactions;

     

    (iii)     The
sale, lease, exchange or other transfer (in one transaction or a series of
related transactions) of all or substantially all of the assets of the Company;
or

     

    (iv)     The
liquidation or dissolution of the Company or the Company ceasing to do
business.

     

    3.           Compensation.

     

    (a)           Base
Salary.  While you are employed hereunder, the Company will pay
you a base salary at the annual rate of $275,000 (the “Base
Salary”).  The Base Salary will be reviewed and will be adjusted upward, (but not
downward) no less frequently than annually.  The Base Salary will be
payable in substantially equal installments in accordance with the Company’s
payroll practices as in effect from time to time.  The Company will
deduct from each such installment any amounts required to be deducted or
withheld under applicable law or under any employee benefit plan in which you
participate.

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    (b)          Annual
Bonus.  The Company will pay you a bonus of up to thirty (30%)
of your base salary on each year anniversary of the Commencement Date the
“Annual Bonus” based on your performance in accordance with criteria established
by you and the Board, provided that in no event will the Annual Bonus be less
than $30,000.

     

    (c)           Equity
Compensation.  You will be granted options to purchase shares
of the Common Stock (the “Performance Option”). The exercise price for the
Performance Option will be the fair market value per share of the Common Stock
on the date the Performance Option is granted. The Performance Option (i) will
be an incentive stock option to the extent permissible under applicable law,
(ii) will become vested and exercisable based upon the achievement as determined
by the Board, (iii) will otherwise be on terms and conditions substantially
similar to the Option and (iv) will be evidenced by a stock option agreement
substantially similar to the Option Agreement.

     

     (d)         Vacation.  You
will be entitled to paid vacation in each calendar year and paid holidays and
personal days in accordance with the Company’s policies for its senior
executives as in effect from time to time, but not less than 15 days paid
vacation, 7 paid sick days, and 5 paid personal days in each calendar
year.  Accrued unused vacation may be carried over from year to
year.

     

     (e)          Fringe
Benefits.  You will be entitled to participate in the same
manner as other senior executives of the Company in any employee benefit plans
which the Company provides or may establish for the benefit of its senior
executives generally (including, without limitation, group life, disability,
medical, dental and other insurance, tax benefit and planning services, 401(k),
flexible spending account, retirement, pension, profit-sharing and similar
plans) (collectively, the “Fringe Benefits”), provided that the Fringe Benefits
will not include any stock option or similar plans relating to the grant of
equity securities of the Company.  The company will pay annual
membership fees for you to maintain membership at the Union League of
Philadelphia or another private club of your choice.  The Company will
furnish for your use a late model automobile/Truck, or provide a $825.00 monthly
payment to cover the cost of a late model.  In addition all gasoline
for the vehicle will be paid for by the company.  InVivo Therapeutics
will also provide up to $3,200 per month for living expenses.

     

    (f)           Life Insurance; Disability
Insurance.  The Company, at its expense, will purchase life
insurance on your life in the face amount of not less than $1 million with a
beneficiary designated by you. The Company will also
arrange disability insurance on your behalf [and at your expense] with annual
benefits in an amount equal to 60% of your Base Salary.  The Company
will take such steps as are reasonable, including a tax gross up, to ensure that
you or your beneficiaries do not incur any tax liability with regard to either
the amount of the premium payment or the benefits payable from such
insurance.

     

    (g)          Reimbursement of
Expenses.  The Company will reimburse you for all ordinary and
reasonable out-of-pocket business expenses that are incurred by you in
furtherance of the Company’s business in accordance with the Company’s policies
with respect thereto as in effect from time to time.

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     (h)         Indemnification.  The
Company will indemnify you to the extent permitted by its charter and by-laws
and by applicable law against all costs, charges and expenses, including,
without limitation, attorneys’ fees, incurred or sustained by you in connection
with any action, suit or proceeding to which you may be made a party by reason
of being an officer, director or employee of the Company.  In
connection with the foregoing, you will be covered under any liability insurance
policy that protects other officers of the Company.

     

    4.           Severance
Compensation.

     

    (a)          Definition of Accrued
Obligations.  For purposes of this Agreement, “Accrued
Obligations” means (i) the portion of your Base Salary as has accrued prior to
any termination of your employment with the Company and has not yet been paid,
(ii) an amount equal to the value of your accrued unused vacation days, (iii)
the amount of any Annual Bonus earned and accrued but not yet paid and (iv) the
amount of any expenses properly incurred by you on behalf of the Company prior
to any such termination and not yet reimbursed.

     

    (b)          Death or
Disability.  If your employment hereunder is terminated as a
result of your death or Disability:

     

    (i)           The
Company will pay the Accrued Obligations to you (or your estate) promptly
following such termination.

     

    (ii)          The
Company will continue to pay you (or your estate) an amount equal to the Base
Salary at the rate in effect at the date of such termination in accordance with
Section 3(a) of this Agreement for the period commencing on the date of such
termination and ending  eighteen (18) months thereafter.

     

    (iii)         The
Company will continue to provide you or your covered beneficiaries with the
Fringe Benefits for so long as it is obligated to continue payments equal to the
Base Salary pursuant to Section 4(b)(ii) above, subject to applicable law and
the terms of the respective policies.

     

     (c)          Termination for Cause or in
the Absence of a Good Reason.  If your employment hereunder is
terminated either by the Company for Cause or by you in the absence of a Good
Reason (either pursuant to Section 2(a)(iii)(A) above or by delivery by you of a
Non-Renewal Notice), the Company will pay the Accrued Obligations to you
promptly following such termination.

     

    (d)           Termination Without Cause or
for a Good Reason.  If your employment hereunder is terminated
either by the Company without Cause (either pursuant to Section 2(a)(ii)(c)
above or by delivery of a Non-Renewal Notice by the Company) or by you for a
Good Reason:

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    (i)           The
Company will pay the Accrued Obligations to you promptly following such
termination.

     

    (ii)          The
Company will continue to pay you an amount equal to the Base Salary at the rate
in effect at such termination in accordance with Section 3(a) of this Agreement
for the period commencing on the date of such termination and for a period of
eighteen (18) months.

     

    (iii)         The
Company will continue to provide you with the Fringe Benefits for so long as it
is obligated to continue payments equal to the Base Salary pursuant to Section
4(d)(ii) above, subject to applicable law and the terms of the respective
policies.

     

    (iv)    
    The Company will continue to pay you the Annual Bonus in
accordance with Section 3(b)(ii) of this Agreement during the period commencing
on the date of such termination and ending on the date of the end of the then
current Term.  The amount of such bonus after the date of such
termination will equal the greater of (A) the last such bonus paid before the
date of such termination, or (B) the average of three most recent such bonuses
paid before the date of such termination (and all such prior bonuses if less
than three).

     

    (e)           No Duty to
Mitigate.  Notwithstanding any other provision of this
Agreement, (i) you will have no obligation to mitigate your damages for any
breach of this Agreement by the Company or for any termination of this
Agreement, whether by seeking employment or otherwise and (ii) the amount of any
benefit due to you after the date of such termination pursuant to this Agreement
will not be reduced or offset by any payment or benefit that you may receive
from any other source.

     

    5.           Prohibited
Competition.

     

    (a)           Certain Acknowledgements and
Agreements.

     

    (i)           We
have discussed, and you recognize and acknowledge the competitive and
proprietary aspects of the business of the Company.

     

    (ii)          You
acknowledge that a business will be deemed competitive with the Company if it
performs any of the services or manufactures or sells any of the products
provided or offered by the Company or if it performs any other services and/or
engages in the production, manufacture, distribution or sale of any product
similar to services or products, which services or products were performed,
produced, manufactured, distributed or sold by the Company during the period
while you are employed hereunder.

    

    (iii)         You
further acknowledge that, while you are employed hereunder, the Company will
furnish, disclose or make available to you Confidential Information (as defined
below) related to the Company’s business and that the Company may provide you
with unique and specialized training.  You also acknowledge that such
Confidential Information and such training have been developed and will be
developed by the Company through the expenditure by the Company of substantial
time, effort and money and that all such Confidential Information and training
could be used by you to compete with the Company.

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    (iv)        For
purposes of this Agreement, “Confidential Information” means confidential and
proprietary information of the Company, whether in written, oral, electronic or
other form, including but not limited to, information and facts concerning
business plans, customers, future customers, suppliers, licensors, licensees,
partners, investors, affiliates or others, training methods and materials,
financial information, sales prospects, client lists, inventions, or any other
scientific, technical or trade secrets of the Company or of any third party
provided to you or the Company under a condition of confidentiality, provided
that Confidential Information will not include information that is (1) in the
public domain other than through any fault or act by you, (2) known to you prior
to its disclosure to you in the course of your employment hereunder, or (3)
lawfully disclosed to you by a source other than the Company which source has a
legal right to disclose such information.

     

    (b)          Non-Competition;
Non-Solicitation.  During the period while you are employed
hereunder and for a period of one year following the termination of your
employment hereunder for any reason or for no reason you will not, without the
prior written consent of the Company:

     

    (i)           For
yourself or on behalf of any other person or entity, directly or indirectly,
either as principal, partner, stockholder, officer, director, member, employee,
consultant, agent, representative or in any other capacity, own, manage, operate
or control, or be concerned, connected or employed by, or otherwise associate in
any manner with, engage in, or have a financial interest in, any business which
is directly or indirectly competitive with the business of the Company (each, a
“Restricted Activity”) within a 75 mile radius of the Company’s facility located
at One Broadway 14th Floor,
Cambridge, MA  02142 (the “Restricted Territory”), except that (A)
nothing contained herein will preclude you from purchasing or owning securities
of any such business if such securities are publicly traded, and provided that
your holdings do not exceed [three] percent of the issued and outstanding
securities of any class of securities of such business, and (B) nothing
contained herein will prevent you from engaging in a Restricted Activity for or
with respect to any subsidiary, division or affiliate or unit (each, a “Unit”)
of an entity if that Unit is not engaged in any business which is competitive
with the business of the Company, irrespective of whether some other Unit of
such entity engages in such competition (as long as you do not engage in a
Restricted Activity for such other Unit); or

    

    (ii)          Either
individually or on behalf of or through any third party, directly or indirectly,
solicit, divert or appropriate or attempt to solicit, divert or appropriate, for
the purpose of competing with the Company, any customers or patrons of the
Company, or any prospective customers or patrons with respect to which the
Company has developed or made a sales presentation (or similar offering of
services); or

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    (iii)         Either
individually or on behalf of or through any third party, solicit, entice or
persuade or attempt to solicit, entice or persuade any employee of or consultant
to the Company to leave the service of the Company.

     

    Notwithstanding
the above, the Company acknowledges that this Agreement is not intended to
interfere with your future job opportunities.

     

    (c)           Survival of Acknowledgements
and Agreements.  Your acknowledgements and agreements set forth
in this Section 5 will survive the termination of your employment hereunder for
any reason or for no reason.

     

    6.           Protected
Information.  You will at all times, both during the period
while you are employed hereunder and after the termination of your employment
hereunder for any reason or for no reason, maintain in confidence and will not,
without the prior written consent of the Company, use, except in the course of
performance of your duties for the Company or by court order, disclose or give
to others any Confidential Information.  Upon the termination of your
employment hereunder for any reason or for no reason, you will return to the
Company all tangible Confidential Information and copies thereof (regardless how
such Confidential Information or copies are maintained).

     

    7.           Ownership of Ideas,
Copyrights and Patents.

     

    (a)           Property of the
Company.  All ideas, discoveries, creations, manuscripts and
properties, innovations, improvements, know-how, inventions, designs,
developments, apparatus, techniques, methods, biological processes, cell lines,
laboratory notebooks and formulae (collectively the “Inventions”) which may be
used in the business of the Company, whether patentable, copyrightable or not,
which you may conceive, reduce to practice or develop while you are employed
hereunder, alone or in conjunction with another or others, and whether at the
request or upon the suggestion of the Company or otherwise, will be the sole and
exclusive property of the Company, and that you will not publish any of the
Inventions without the prior written consent of the Company.  You
hereby assign to the Company all of your right, title and interest in and to all
of the foregoing.

    

     (b)         Cooperation.  At
any time during your employment hereunder or after the termination of your
employment hereunder for any reason or for no reason, you will fully cooperate
with the Company and its attorneys and agents in the preparation and filing of
all papers and other documents as may be required to perfect the Company’s
rights in and to any of such Inventions, including, but not limited to, joining
in any proceeding to obtain letters patent, copyrights, trademarks or other
legal rights with respect to any such Inventions in the United States and in any
and all other countries, provided that the Company will bear the expense of such
proceedings, and that any patent or other legal right so issued to you
personally will be assigned by you to the Company or its designee without charge
by you.  The Company will reimburse you for reasonable expenses
incurred by you in connection with the performance of your obligations under
this Section 7.

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    

    8.           Records.  Upon
termination of your employment hereunder for any reason or for no reason, you
will deliver to the Company any property of the Company which may be in your
possession, including products, materials, memoranda, notes, records, reports or
other documents or photocopies of the same.

     

    9.           Insurance.  The
Company, in its sole discretion, may apply for and purchase key person life
insurance on your life in an amount determined by the Company with the Company
as beneficiary.  You will submit to any medical or other examinations
and to execute and deliver any applications or other instruments in writing that
are reasonably necessary to effectuate such insurance.

     

    10.         General.

     

    (a)           Notices.  All
notices, requests, consents and other communications hereunder will be in
writing, will be addressed to the receiving party’s address set forth above or
to such other address as a party may designate by notice hereunder, and will be
either (i) delivered by hand, (ii) sent by overnight courier, or (iii) sent by
registered or certified mail, return receipt requested, postage prepaid. All
notices, requests, consents and other communications hereunder will be deemed to
have been given either (i) if by hand, at the time of the delivery thereof to
the receiving party at the address of such party set forth above, (ii) if sent
by overnight courier, on the next business day following the day such notice is
delivered to the courier service, or (iii) if sent by registered or certified
mail, on the fifth business day following the day such mailing is
made.

     

    (b)           Entire
Agreement.  This Agreement and the other agreements
specifically referred to herein, embodies the entire agreement and understanding
between the parties hereto with respect to the subject matter hereof and
supersedes all prior oral or written agreements and understandings relating to
the subject matter hereof. No statement, representation, warranty, covenant or
agreement of any kind not expressly set forth in this Agreement will affect, or
be used to interpret, change or restrict, the express terms and provisions of
this Agreement.

     

    (c)           Modifications and
Amendments.  The terms and provisions of this Agreement may be
modified or amended only by written agreement executed by the parties
hereto.

     

    (d)           Waivers and
Consents.  The terms and provisions of this Agreement may be
waived, or consent for the departure therefrom granted, only by written document
executed by the party entitled to the benefits of such terms or provisions. No
such waiver or consent will be deemed to be or will constitute a waiver or
consent with respect to any other terms or provisions of this Agreement, whether
or not similar. Each such waiver or consent will be effective only in the
specific instance and for the purpose for which it was given, and will not
constitute a continuing waiver or consent.

     

    (e)           Assignment.  \You may not assign your
rights and obligations under this Agreement without the prior written consent of
the Company.

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

    (f)           Benefit.  All
statements, representations, warranties, covenants and agreements in this
Agreement will be binding on the parties hereto and will inure to the benefit of
the respective successors and permitted assigns of each party hereto. Nothing in
this Agreement will be construed to create any rights or obligations except
among the parties hereto, and no person or entity will be regarded as a
third-party beneficiary of this Agreement.

     

    (g)          Governing
Law.  This Agreement and the rights and obligations of the
parties hereunder will be construed in accordance with and governed by the law
of the State of
Delaware, without giving effect to the conflict of law principles
thereof.

     

    (h)          Severability.  The
parties intend this Agreement to be enforced as written. However, (i) if any
portion or provision of this Agreement is to any extent be declared illegal or
unenforceable by a duly authorized court having jurisdiction, then the remainder
of this Agreement, or the application of such portion or provision in
circumstances other than those as to which it is so declared illegal or
unenforceable, will not be affected thereby, and each portion and provision of
this Agreement will be valid arid enforceable to the fullest extent permitted by
law and (ii) if any provision, or part thereof, is held to be unenforceable
because of the duration of such provision, the geographic area covered thereby,
or other aspect of the scope of such provision, the court making such
determination will have the power to reduce the duration, geographic area of
such provision, or other aspect of the scope of such provision, and/or to delete
specific words and phrases (“blue-penciling”), and in its reduced or
blue-penciled form, such provision will then be enforceable and will be
enforced.

     

    (i)           Headings and
Captions.  The headings and captions of the various
subdivisions of this Agreement are for convenience of reference only and will in
no way modify or affect the meaning or construction of any of the terms or
provisions hereof

     

    (j)           No Waiver of Rights, Powers
and Remedies.  No failure or delay by a party hereto in
exercising any right, power or remedy under this Agreement, and no course of
dealing between the parties hereto, will operate as a waiver of any such right,
power or remedy of the party. No single or partial exercise of any right, power
or remedy under this Agreement by a party hereto, nor any abandonment or
discontinuance of steps to enforce any such right, power or remedy, will
preclude such party from any other or further exercise thereof or the exercise
of any other right, power or remedy hereunder. The election of any remedy by a
party hereto will not constitute a waiver of the right of such party to pursue
other available remedies.  No notice to or demand on a party not
expressly required under this Agreement will entitle the party receiving such
notice or demand to any other or further notice or demand in similar or other
circumstances or constitute a waiver of the rights of the party giving such
notice or demand to any other or further action in any circumstances without
such notice or demand.

     

    (k)          Counterparts.  This
Agreement may be executed in two or more counterparts, and by different parties
hereto on separate counterparts, each of which will be deemed an original, but
all of which together will constitute one and the same
instrument.

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

    
      
         

      

      
        12

        
          

        

      

      
         

      

    

    If the
foregoing accurately sets forth our agreement, please so indicate by signing and
returning to us the enclosed copy of this letter.

     

    
      	 
      	
              Very
      truly yours,

            
	 
      	 
      
	 
      	
              InVivo
      Therapeutics Corporation

            
	 
      	 
      	 
      
	 
      	
              By:

            	 
      
	 
      	 
      	
              Frank
      Reynolds, President & CEO

            
	 
      	 
      	
              :

            

    

    

    Accepted
and Approved

    

    
      	
                          

            	 
      	
                   

            	 
      
	
              Print
      Name: Frank Reynolds

            	 
      	
              Date

            

    

     

    
      
         

      

      
        13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}]]